News & Events

Preventing HAIs

Feb 10, 2014 | ADVANCE Executive Insight

Nanosphere's CEO and President highlights the increasing economic burden of healthcare-acquired infections on the U.S. healthcare system and describes the importance of rapid molecular diagnostic testing in the effective management of these critical diseases.

Cutting-edge technology in metro helps limit antibiotics doctors prescribe

Jan 14, 2014 | KSTP Hennepin County News

Hennepin County Medical Center in Minneapolis, Minnesota is featured in a local news broadcast focused on their use of Verigene to help doctors limit the amount of antibiotics they prescribe.

Nanosphere receives FDA clearance for gram-negative bacteria test

Jan 11, 2014 | Infectious Disease News

Nanosphere announced that it has received FDA clearance to market an in vitro diagnostic test for identifying gram-negative bacteria associated with bloodstream infections.

Molecular diagnostics: MDx applications, development continue

Dec 9, 2013 | ADVANCE for Laboratory

Nanosphere's CEO and President argues that the increase in antibiotic-resistant infections underscores the need for greater adoption of molecular diagnostics.

Diagnostics for superbugs

Dec 1, 2013 | Medical Laboratory Observer

Nanosphere's Vice President of Clinical Affairs and Marketing Manager discuss the need for healthcare providers to employ newly developed rapid molecular diagnostic tests for earlier detection in order to limit unnecessary antibiotic usage.

Nanosphere named to Deloitte’s 2013 Technology Fast 500™

Nov 13, 2013 | Nanosphere News

Nanosphere recognized as the 310th fastest growing company in North America by Deloitte LLP.